{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "Connecticut Weekly Desk", "lead_paragraph": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow suit and New Jersey has two bills with bipartisan support. Indeed, a number of states have had similar measures in play over the last year, in addition to the 12 that have already passed such laws. The picture is very different at the federal level, where marijuana is branded as an illegal drug. An amendment to a recent drug safety bill would require all purveyors of state-authorized medical marijuana to be subject to Food and Drug Administration regulation. The senator who introduced this amendment said that making any drug available without F.D.A. review or proof of safety and effectiveness would set a dangerous precedent that would threaten patient safety. Marijuana advocates have opposed the bill, because it would close medical marijuana cooperatives and create barriers to the use of the drug.", "headline": {"main": "Crackpot Legislation"}, "abstract": "Op-Ed article by Dr Henry Miller, Hoover Institution fellow, on rancorous debate over medical marijuana; holds drugs like Sativex, spray that delivers precise dose of drug without causing 'high' that many patients view as undesirable side effect, would both benefit patients and satisfy legal requirement that marketed medicines must be proven safe and effective (M)", "print_page": "15", "word_count": 923, "_id": "4fd27c4a8eb7c8105d8426f9", "snippet": "MANY states nationwide are considering legislation to legalize the medical use of marijuana. Last week, one such bill cleared both houses in Connecticut (but at press time had not yet been signed by the governor), New York appears likely to follow...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9903E2D7143FF934A25755C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SATIVEX (DRUG)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MARIJUANA"}], "byline": {"person": [{"firstname": "Henry", "middlename": "I.", "lastname": "Miller", "rank": 1, "role": "reported", "organization": ""}], "original": "By Henry I. Miller"}, "document_type": "article", "pub_date": "2007-06-17T00:00:00Z", "section_name": "Health; New York and Region; Opinion"}], "meta": {"hits": 11, "offset": 10, "time": 42}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}